Suppr超能文献

用于三聚体寡脱氧核糖核苷酸3´-(2-氯苯基磷酸酯)结构单元溶液相合成的二硫键连接的沉淀性可溶性载体的制备。

Preparation of a disulfide-linked precipitative soluble support for solution-phase synthesis of trimeric oligodeoxyribonucleotide 3´-(2-chlorophenylphosphate) building blocks.

作者信息

Jabgunde Amit M, Molina Alejandro Gimenez, Virta Pasi, Lönnberg Harri

机构信息

Department of Chemistry, University of Turku, FIN-20014 Turku, Finland ; current address: Rega Institute for Medical Research, Minderbroedersstraat 10, KU Leuven, 3000- Leuven, Belgium.

Department of Chemistry, University of Turku, FIN-20014 Turku, Finland.

出版信息

Beilstein J Org Chem. 2015 Sep 7;11:1553-60. doi: 10.3762/bjoc.11.171. eCollection 2015.

Abstract

The preparation of a disulfide-tethered precipitative soluble support and its use for solution-phase synthesis of trimeric oligodeoxyribonucleotide 3´-(2-chlorophenylphosphate) building blocks is described. To obtain the building blocks, N-acyl protected 2´-deoxy-5´-O-(4,4´-dimethoxytrityl)ribonucleosides were phosphorylated with bis(benzotriazol-1-yl) 2-chlorophenyl phosphate. The "outdated" phosphotriester strategy, based on coupling of P(V) building blocks in conjunction with quantitative precipitation of the oligodeoxyribonucleotide with MeOH is applied. Subsequent release of the resulting phosphate and base-protected oligodeoxyribonucleotide trimer 3'-pTpdC(Bz)pdG(ibu)-5' as its 3'-(2-chlorophenyl phosphate) was achieved by reductive cleavage of the disulfide bond.

摘要

本文描述了一种二硫键连接的沉淀性可溶载体的制备及其在三聚体寡聚脱氧核糖核苷酸3´-(2-氯苯基磷酸酯)结构单元的溶液相合成中的应用。为了获得这些结构单元,用双(苯并三唑-1-基)2-氯苯基磷酸酯对N-酰基保护的2´-脱氧-5´-O-(4,4´-二甲氧基三苯甲基)核糖核苷进行磷酸化。采用了基于P(V)结构单元偶联并结合用甲醇对寡聚脱氧核糖核苷酸进行定量沉淀的“过时”的磷酸三酯策略。通过二硫键的还原裂解,随后得到了磷酸和碱基保护的寡聚脱氧核糖核苷酸三聚体3'-pTpdC(Bz)pdG(ibu)-5',其形式为3'-(2-氯苯基磷酸酯)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f456/4660909/70c03d7ac7f3/Beilstein_J_Org_Chem-11-1553-g005.jpg

相似文献

8
Solution phase synthesis of short oligoribonucleotides on a precipitative tetrapodal support.
Beilstein J Org Chem. 2014 Sep 29;10:2279-85. doi: 10.3762/bjoc.10.237. eCollection 2014.

引用本文的文献

1
Stereo-Controlled Liquid Phase Synthesis of Phosphorothioate Oligonucleotides on a Soluble Support.
J Org Chem. 2023 Jul 21;88(14):10156-10163. doi: 10.1021/acs.joc.3c01006. Epub 2023 Jul 10.
2
Synthesis of fully protected trinucleotide building blocks on a disulphide-linked soluble support.
RSC Adv. 2021 Jan 20;11(7):3892-3896. doi: 10.1039/d0ra10941j. eCollection 2021 Jan 19.
3
Preparation of trinucleotide phosphoramidites as synthons for the synthesis of gene libraries.
Beilstein J Org Chem. 2018 Feb 13;14:397-406. doi: 10.3762/bjoc.14.28. eCollection 2018.
4
Synthesis of oligonucleotides on a soluble support.
Beilstein J Org Chem. 2017 Jul 12;13:1368-1387. doi: 10.3762/bjoc.13.134. eCollection 2017.

本文引用的文献

1
Solution phase synthesis of short oligoribonucleotides on a precipitative tetrapodal support.
Beilstein J Org Chem. 2014 Sep 29;10:2279-85. doi: 10.3762/bjoc.10.237. eCollection 2014.
2
Development of RNA interference-based therapeutics and application of multi-target small interfering RNAs.
Nucleic Acid Ther. 2014 Aug;24(4):302-12. doi: 10.1089/nat.2014.0480. Epub 2014 May 5.
3
CpG still rocks! Update on an accidental drug.
Nucleic Acid Ther. 2012 Apr;22(2):77-89. doi: 10.1089/nat.2012.0340. Epub 2012 Feb 21.
4
RNA-based therapeutics: current progress and future prospects.
Chem Biol. 2012 Jan 27;19(1):60-71. doi: 10.1016/j.chembiol.2011.12.008.
5
RNA therapeutics: beyond RNA interference and antisense oligonucleotides.
Nat Rev Drug Discov. 2012 Jan 20;11(2):125-40. doi: 10.1038/nrd3625.
6
Silencing disease genes in the laboratory and the clinic.
J Pathol. 2012 Jan;226(2):365-79. doi: 10.1002/path.2993. Epub 2011 Nov 9.
7
Synthesis of RNA using 2'-O-DTM protection.
J Am Chem Soc. 2006 Sep 27;128(38):12356-7. doi: 10.1021/ja0636587.
8
A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes.
Angew Chem Int Ed Engl. 2002 Jul 15;41(14):2596-9. doi: 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4.
10
Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics.
J Clin Invest. 2000 Nov;106(10):1197-202. doi: 10.1172/JCI11631.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验